Merck (www.MerckGroup.com), one of the leading science and technology companies announced the appointment of Paolo Carli as Head of Middle East, Africa & Turkey (MEA) region for its healthcare business. In his new role, Paolo will be responsible for leading the commercial operations for Merck across MEA.

Commenting on his appointment Paolo Carli said “Merck prepares to celebrate its 350th year in the pharmaceutical business in 2018. Being a strategic region for Merck, we are committed to excel innovation and create value for patients across this region. I am delighted to lead the MEA team. Our innovative treatment options and sustainable commitment for patients will move us to the next level.”

Paolo Carli has decades of business and pharmaceutical experience demonstrating a proven track record of continuous success under his leadership. His expertise and industry knowledge will be critical in MEA as Merck builds on strategic innovation to elevate the healthcare standards, improve patient programs and prepares launches of new products.

Paolo Carli joined Merck in 2008, as the member of the Mergers & Acquisitions team in Darmstadt, Germany. In that role, he actively participated in the execution of key transactions for the Merck Group. He successfully led Middle East and Egypt in the last 5 years and now expands his responsibilities to Turkey and Africa.

Prior to joining Merck, Carli worked with Deutsche Bank, both in Italy and in Germany, where he successfully contributed to the regional expansion of the retail franchise in Europe and in several emerging markets such as India, China, Turkey, and Vietnam.

Paolo Carli holds a degree in Economics from the University of Turin and an Executive MBA from Ashridge Business School in the UK. Paolo is settled in Dubai, UAE with his wife and two children.